G3 40 Radiopaque Bone Cement
by G21 S.R.L. Italy EUDAMED510(k)
510(k) K193061 Product code LOD
Overview
The G3 40 Radiopaque Bone Cement is a radiopaque orthopedic bone cement designed for vertebral augmentation and fixation procedures. It is formulated to provide structural support and stability to bone, particularly in spinal surgeries, while allowing radiographic visualization during and after implantation.
This device is supplied as a sterile, single-use product intended for use in orthopedic settings. It is classified as a Class II medical device under FDA regulations and has received FDA 510(k) clearance and MDD authorization. The cement is packaged in a radiopaque formulation to ensure visibility under X-ray imaging, and it is supplied in a specific formulation (G3 40) for precise application in surgical procedures.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK193061 | Date19 Mar 2020 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- LOD
- FDA applicant
- G21, S.R.L.
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3027
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Other devices from G21 S.R.L.
Questions
What is the primary clinical application for the G3 40 Radiopaque Bone Cement, and why is radiopacity important in this context?
The G3 40 Radiopaque Bone Cement is specifically designed for vertebral augmentation and fixation procedures, such as spinal surgeries. Its radiopacity ensures clear visibility under X-ray imaging, which is critical for precise placement, monitoring of the procedure, and post-operative assessment of the implanted cement within the spine.
Is the G3 40 Radiopaque Bone Cement intended for single-use or can it be reused after sterilization?
The G3 40 Radiopaque Bone Cement is supplied as a sterile, single-use product. This design ensures patient safety by eliminating the risk of cross-contamination and maintaining sterility throughout its intended use in orthopedic settings.
What regulatory pathways has the G3 40 Radiopaque Bone Cement undergone, and what does this mean for its use in clinical settings?
The G3 40 Radiopaque Bone Cement has received FDA 510(k) clearance and MDD authorization, confirming it meets regulatory standards for safety and effectiveness. The FDA classification as a Class II device indicates it has undergone rigorous review by the Orthopedic (OR) Advisory Committee, ensuring it is suitable for vertebral augmentation and fixation procedures as intended.
How is the G3 40 Radiopaque Bone Cement packaged, and what does this imply about its handling and storage?
The G3 40 Radiopaque Bone Cement is supplied in a sterile, single-use packaging designed for orthopedic use. While the exact packaging details aren’t specified, the sterility and single-use nature imply it should be stored in a clean, dry environment, protected from moisture and extreme temperatures, and used immediately after opening to maintain its integrity and effectiveness.
Properties & raw data
Show properties, registry sources and raw records
Sources (2)
- FDA 510(k) K193061
- EUDAMED